In the United States, the price of MS Care exceeds 85 billion dollars

By Robert Preidt Health Day Journalist
health day reporter

THURSDAY, April 14, 2022 (HealthDay News) — In 2019 alone, multiple sclerosis (MS) cost Americans an estimated $85.4 billion, according to a new study.

This amount included more than $63 billion in direct medical costs and $22 billion in indirect non-medical costs.

“The results of this study help underscore the burden of MS in the United States and we hope that our findings will inform decision-making regarding MS-related healthcare resources,” said study author Bruce. Baby. He is executive vice president for research at the National Multiple Sclerosis Society.

MS is an unpredictable disease of the central nervous system, in which a person’s immune system attacks the brain and spinal cord. Symptoms can include numbness, tingling, mood changes, memory problems, pain, fatigue, blindness and paralysis, according to the company.

At nearly $38 billion, prescription drugs accounted for the largest portion (54%) of direct medical costs. This was followed by drugs administered in clinics at $6.7 billion (12%) and outpatient care at $5.5 billion (9%), the researchers reported.

Compared to someone without MS, the average MS patient incurred over $65,000 in additional medical costs. This included $35,000 for drugs, according to the study.

The annual cost for someone taking MS drugs ranged from $57,000 to nearly $93,000, according to the report published online April 13 in the journal Neurology.

But drugs and health care are not the only factors in the overall economic burden of MS. People with the neurological condition may have to limit their work or be unable to work at all, reducing their productivity and income.

And patients’ family members may have to give up their jobs to act as caregivers, the study authors noted.

“Multiple sclerosis is an expensive disease to treat, and the debilitating effects of MS can cause significant disruption to daily life, including work, physical independence, mobility and social interaction,” Bebo said in A press release.

For the study, the researchers analyzed the health and insurance claims of just under 10,600 people with MS and nearly 106,000 others. They also surveyed about 950 participants and their caregivers about indirect costs, such as lost employment or lost productivity at work, the cost of paid and unpaid caregivers, and home modifications.

“Right now in the United States there are approximately one million adults with MS and we estimate that by 2039 there will be nearly 1.2 million people with MS,” Bebo said. . “With that, the economic burden will increase to $108.1 billion.”

More information

The National Multiple Sclerosis Society has more information on MS.

THE SOURCE: Neurologypress release, April 13, 2022

Richard L. Militello